Content about Triglyceride

June 5, 2013

Survey finds widespread ignorance about triglycerides' role in cardiovascular health

Most Americans have little understanding of the importance of managing fats known as triglycerides to maintain cardiovascular health, according to a new survey.

MADISON, N.J. — Most Americans have little understanding of the importance of managing fats known as triglycerides to maintain cardiovascular health, according to a new survey.

To conduct the survey, researchers from Fairleigh Dickinson University's PublicMind polled 600 adults aged 40 and older, finding that 54% of respondents didn't know if it was better to have high or low levels of triglycerides, and 45% of those diagnosed as having high cholesterol didn't know.

May 28, 2013

AstraZeneca to buy Omthera for $323 million

Anglo-Swedish drug maker AstraZeneca will buy Omthera Pharmaceuticals for $323 million, the two companies said.

PRINCETON, N.J. — Anglo-Swedish drug maker AstraZeneca will buy Omthera Pharmaceuticals for $323 million, the two companies said Tuesday.

Omthera, based in Princeton, N.J., develops drugs for dyslipidemia, conditions that result in abnormal levels of lipids in the blood. Its lead products include Epanova, an experimental drug for patients with high triglycerides that's based on omega-3 fatty acids; Omthera has finished late-stage clinical trials of the drug and plans to file for Food and Drug Administration approval in mid-2013.

May 21, 2013

Nordic Naturals introduces OTC Pro EPA Elite

Nordic Naturals now is offering Pro EPA Elite, a powerful EPA-only concentrate available without a prescription, the company stated.

WATSONVILLE, Calif. — Nordic Naturals now is offering Pro EPA Elite, a powerful EPA-only concentrate available without a prescription, the company stated.

With 1600 mg of the omega-3 eicosapentaenoic acid (EPA) in each serving, Pro EPA Elite provides high intensity, therapeutic support for healthy triglyceride levels and heart health, while promoting key anti-inflammatory pathways.

May 31, 2012

Jarrow Formulas intros omega-3 supplement boasting higher bioavailability

Jarrow Formulas earlier this month launched PhosphOmega, a phospholipid-omega-3 fatty acid complex.

LOS ANGELES — Jarrow Formulas earlier this month launched PhosphOmega, a phospholipid-omega-3 fatty acid complex. According to the company, phospholipid-bound omega-3s have higher bioavailability than ordinary fish oils.

“The omega-3s in seafood are consumed both as phospholipids and triglycerides,” Jarrow Formulas marketing director Rory Lipsky said. “For example, 80% of the fatty acids in trout are phospholipids and 20% are triglycerides. PhosphOmega provides omega-3s in both the triglyceride and phospholipid forms.”

April 3, 2012

Amylin seeks FDA approval for metreleptin

Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

SAN DIEGO — Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

July 5, 2011

Santal's Assurance Blood Health Support arrives at Walgreens, Rite Aid

Santal Solutions last week announced its dietary supplement Assurance Blood Health Support has gained distribution through Rite Aid and Walgreens.

NEENAH, Wis. — Santal Solutions last week announced its dietary supplement Assurance Blood Health Support has gained distribution through Rite Aid and Walgreens.

“We are excited that Assurance Blood Health Support is on the shelves of major retailers,” Santal president Dennis Torkko said. “This reinforces the strength of the product and provides an all-natural option for those individuals that are concerned about blood sugar, cholesterol and triglyceride levels.”

February 25, 2011

Fatty liver may impose diabetes risk

Over the years, a fatty liver has become an indicator of obesity and insulin resistance among humans, but researchers have found that people with fatty livers are five times more likely to develop Type 2 diabetes than their healthier counterparts.

NEW YORK — Over the years, a fatty liver has become an indicator of obesity and insulin resistance among humans, but researchers have found that people with fatty livers are five times more likely to develop Type 2 diabetes than their healthier counterparts.

February 24, 2011

To your health: Light to moderate drinking may lower heart disease risk, researchers find

The Spaniards drink Rioja wine with a hearty “Salud!,” while the Irish knock back Jameson whiskey and Guinness beer with “Slainte.” Nobody can say who coined the two calls to imbibe, both of which mean “health,” but according to two recent studies, it looks as though they were on to something.

NEW YORK — The Spaniards drink Rioja wine with a hearty “Salud!,” while the Irish knock back Jameson whiskey and Guinness beer with “Slainte.” Nobody can say who coined the two calls to imbibe, both of which mean “health,” but according to two recent studies, it looks as though they were on to something.

January 24, 2011

Rite Aid hearts Wellness+

Rite Aid on Monday introduced its annual national education and prevention campaign against heart disease in observation of American Heart Month in February.

CAMP HILL, Pa. — Rite Aid on Monday introduced its annual national education and prevention campaign against heart disease in observation of American Heart Month in February.